FAQ

Fluticasone Propionate, Salmeterol Xinafoate Drug Combination

Known as: Fluticasone Propionate, Salmeterol Xinafoate Drug Combination [Chemical/Ingredient], Fluticasone Propionate - Salmeterol, Fluticasone Propionate Salmeterol Xinafoate Combination 
A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2016
01220102016

Related topics

Related topics

16 relations

Narrower (4)

AdvairAdvair DiskusAdvair HFASeretide

Broader (3)

Bronchodilator AgentsGlucocorticoidsSympathomimetics
In Bloodadministration & dosageagonistsantagonists & inhibitors
(More)

Related mentions per year

Related mentions per year

1940-2018
19401960198020002020
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
agonists
Glucocorticoids
Bronchodilator Agents
Sympathomimetics
chemical synthesis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma.
BACKGROUND In developing countries, there is a need for access to affordable inhaled respiratory medicines. This study tested the… (More)
  • table 1
Is this relevant?
2014
2014
Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
BACKGROUND Comparative effectiveness of the budesonide-formoterol fumarate dihydrate combination (BFC) and the fluticasone… (More)
Is this relevant?
2011
2011
Outcomes and Costs Associated With Initial Maintenance Therapy With Fluticasone Propionate-Salmeterol Xinafoate 250 μg/50 μg Combination Versus Tiotropium In Commercially Insured Patients With COPD
Purpose: To compare, in commercially-insured individuals ≥40 years old, the risk of chronic obstructive pulmonary disease (COPD… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2010
2010
Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.
Limited information exists comparing fluticasone propionate/salmeterol combination (FSC) versus montelukast (MON) in patients… (More)
  • figure 1
  • table 2
  • figure 2
  • table 3
  • figure 3
Is this relevant?
2010
2010
Safety and Efficacy of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler Compared with Fluticasone Propionate/Salmeterol Diskus in Patients with Chronic Obstructive…
PURPOSE To provide information on the efficacy and safety of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?